Lytica Therapeutics
CAMBRIDGE, MA · Biotechnology · 9 employees
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Funding history
- Funding Round — $6.0M — Apr 2025
- Funding Round — $1.8M — Aug 2024
- Series seed — $4.1M — Mar 2024
Recent signals
- Apr 11, 2025: Raised $6.0M
- Aug 19, 2024: Raised $1.8M
- Mar 12, 2024: Raised $4.1M in Series seed
See plans & pricing → Track Lytica Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.